Phosphorus ( DrugBank: Phosphorus )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
238ビタミンD抵抗性くる病/骨軟化症2

238. ビタミンD抵抗性くる病/骨軟化症


臨床試験数 : 28 薬物数 : 20 - (DrugBank : 9) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 16
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-JapicCTI-101332
01/9/201002/11/2010Therapeutic use of Z-521Therapeutic use of oral sodium phosphate (Z-521) in primary hypophosphatemic rickets (familial rickets, X-linked hypophosphatemia, vitamin D-resistant rickets) primary hypophosphatemic ricketsIntervention name : Z-521
Dosage And administration of the intervention : 300-3000mg inorganic phosphorus is orally administered in 3 or 4 times per day
Zeria Pharmaceutical Co., Ltd.NULL114BOTH10Phase 3NULL
2ChiCTR-OOC-16010095
2006-01-012016-12-07Oral Phosphate Supplements Play an Important Role in Improving the Bone Mineral Density of Hypophosphatemic Osteomalacia PatientsEffect of Phosphate on hypophosphatemia Hypophosphatemic OsteomalaciaA1:received phosphate solution doses at a frequency dependent upon measured serum phosphorus levels;A2:received phosphate solution doses only every three to four days;A3:received no phosphate solution;A:Hypophosphatemic Osteomalacia;B:Control;The Second Xiangya Hospital, Central South UniversityNULLCompletedBothA1:3;A2:5;A3:3;A:21;B:105;China